Managing Director
Mark Turco joined the Healthcare Investment Banking team at Ziegler in 2014. He has nearly 20 years of investment banking experience and works primarily with healthcare technology and tech-enabled services companies. Mark advises clients on mergers and acquisitions, capital raising and restructuring transactions, as well as partnership development.
Mark has completed numerous M&A and capital raising transactions for healthcare companies across a wide spectrum of healthcare subsectors, including: revenue cycle management, digital health, data analytics, federal health IT, post-acute technology, payments and business process outsourcing. Select clients include HBCS Revenue Cycle, Loyale, Medical Advantage, Stanson Health, Essex Management, Audacious Inquiry, Envera Health and HealthPay24.
Prior to joining Ziegler, he was a Director in the investment banking division at Alvarez & Marsal Securities focused on financial restructuring and distressed M&A.
Mark earned a B.A. in history from Yale University. He holds Series 7, 52, 63 and 79 securities licenses.